Cargando…
Commentary on: A call for better reporting of trials using surrogate primary endpoints
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323348/ https://www.ncbi.nlm.nih.gov/pubmed/35910669 http://dx.doi.org/10.1002/trc2.12339 |
| _version_ | 1784756528475013120 |
|---|---|
| author | Cummings, Jeffrey |
| author_facet | Cummings, Jeffrey |
| author_sort | Cummings, Jeffrey |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9323348 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93233482022-07-30 Commentary on: A call for better reporting of trials using surrogate primary endpoints Cummings, Jeffrey Alzheimers Dement (N Y) Reply John Wiley and Sons Inc. 2022-07-26 /pmc/articles/PMC9323348/ /pubmed/35910669 http://dx.doi.org/10.1002/trc2.12339 Text en © 2022 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Reply Cummings, Jeffrey Commentary on: A call for better reporting of trials using surrogate primary endpoints |
| title | Commentary on: A call for better reporting of trials using surrogate primary endpoints |
| title_full | Commentary on: A call for better reporting of trials using surrogate primary endpoints |
| title_fullStr | Commentary on: A call for better reporting of trials using surrogate primary endpoints |
| title_full_unstemmed | Commentary on: A call for better reporting of trials using surrogate primary endpoints |
| title_short | Commentary on: A call for better reporting of trials using surrogate primary endpoints |
| title_sort | commentary on: a call for better reporting of trials using surrogate primary endpoints |
| topic | Reply |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323348/ https://www.ncbi.nlm.nih.gov/pubmed/35910669 http://dx.doi.org/10.1002/trc2.12339 |
| work_keys_str_mv | AT cummingsjeffrey commentaryonacallforbetterreportingoftrialsusingsurrogateprimaryendpoints |